Didactics-Ovarian Cancer didactic

Video Transcription

Video Summary

The speaker discusses the treatment options for ovarian cancer, specifically focusing on the use of primary debulking surgery versus neoadjuvant chemotherapy followed by interval debulking surgery. They summarize some key findings from studies comparing the two approaches, including the fact that overall survival rates are similar between the two groups. They also mention that neoadjuvant chemotherapy is associated with lower rates of adverse effects and mortality compared to primary debulking surgery. The speaker provides recommendations for selecting the appropriate treatment approach based on disease severity and patient characteristics. They also discuss the importance of evaluating a patient's medical status prior to cytoreductive surgery and suggest using an algorithm to assess the risk of post-operative complications. The timing of interval debulking surgery is also discussed, with the speaker highlighting the importance of monitoring the patient's response to chemotherapy before deciding on the appropriate timing for surgery.

Asset Subtitle

Thomas Randall
October 2023
Rwanda ECHO

Keywords

ovarian cancer

treatment options

primary debulking surgery

neoadjuvant chemotherapy

interval debulking surgery